Emcure Pharmaceuticals, founded by Namita Thapar's father, is set to raise around Rs. 1,952 crore through its IPO. Thapar, the Executive Director, will sell a 3.5% stake in the company, potentially making Rs. 126 crore. With key therapeutic areas and a strong global presence, Emcure's debut on the market comes at an opportune time for India's pharma sector.
Emcure Pharmaceuticals: A Rising Star in the Pharmaceutical Industry
Emcure Pharmaceuticals, a leading Indian pharmaceutical company, is poised to make its debut on the stock market through an initial public offering (IPO). The company, founded by Namita Thapar's father, Satish Mehta, plans to raise around Rs. 1,952 crore through the IPO.
Background
Emcure Pharmaceuticals was established in 1981 in Pune, India. The company has a strong presence in key therapeutic areas such as cardiology, diabetes, and oncology. It has a global footprint, with operations in over 100 countries.
Namita Thapar, the Executive Director of Emcure Pharmaceuticals, is a renowned businesswoman and angel investor. She is known for her participation as a judge on the popular Indian television show "Shark Tank India."
IPO Details
Emcure Pharmaceuticals is set to sell shares worth Rs. 1,952 crore through its IPO. The price band for the IPO has been set at Rs. 419-422 per share. The issue will open for subscription on March 18, 2023, and close on March 20, 2023.
Thapar, who owns a 3.5% stake in Emcure Pharmaceuticals, is expected to sell a portion of her shares in the IPO. This could potentially net her around Rs. 126 crore.
Opportune Time for Indian Pharma Sector
The IPO of Emcure Pharmaceuticals comes at an opportune time for the Indian pharmaceutical sector. The sector is expected to grow at a compounded annual growth rate (CAGR) of around 10% over the next five years. Factors such as increasing healthcare spending, government initiatives, and a growing aging population are driving this growth.
Top 5 FAQs
1. When is Emcure Pharmaceuticals' IPO opening?
The IPO will open for subscription on March 18, 2023, and close on March 20, 2023.
2. What is the price band for the IPO?
The price band for the IPO is Rs. 419-422 per share.
3. How much is Namita Thapar expected to sell in the IPO?
Thapar, who owns a 3.5% stake in Emcure Pharmaceuticals, is expected to sell a portion of her shares in the IPO. This could potentially net her around Rs. 126 crore.
4. Which are Emcure Pharmaceuticals' key therapeutic areas?
Emcure Pharmaceuticals' key therapeutic areas include cardiology, diabetes, and oncology.
5. What is the company's global footprint?
Emcure Pharmaceuticals has a global footprint, with operations in over 100 countries.
As VMS TMT Ltd. prepares to launch its initial public offering, the grey market premium for its mainboard issue is already showing signs of high demand. The company, which manufactures TMT Bars and deals in scrap and binding wires, is set to go public on Wednesday, September 17. With the GMP currently at Rs 23 per share, investors are estimating a potential listing gain of 23.23% per share. The company is offering 1.5 crore shares at a price band of Rs 94 to Rs 99 per share, with a minimum investment of Rs 14,850 for retail investors.
Despite President Trump's dismissal of a top Federal Reserve official, investors shrugged off concerns and pushed stocks higher. The Dow, S&P 500, and Nasdaq all finished the day in positive territory, with the Dow hitting a new record closing high. While the move to remove the official raises questions about the Fed's independence, investors are focused on upcoming economic indicators, including a report on inflation and highly anticipated earnings reports from tech giants like Nvidia. Meanwhile, the digital currency Bitcoin continues to struggle, dropping below $110,000 for the first time in two weeks.
In an effort to reduce reliance on China for key minerals used in advanced technologies, India is exploring partnership with a rebel group in Myanmar to secure rare earth samples. The Ministry of Mines has directed state-owned and private companies to collect samples from Kachin Independence Army-controlled mines and test them in domestic labs. This move comes in light of China's recent export restrictions on rare earth magnets, causing disruptions in global supply chains.
Oracle chairman Larry Ellison, who hails from the Bronx, has surpassed Tesla CEO Elon Musk as the richest person in the world with a net worth of $405 billion. This jump in wealth was reported by Barron's on Wednesday, putting Ellison ahead of Musk's net worth of $390 billion. This milestone marks a shift in the top spot amongst the world's wealthiest individuals.
The US Producer Price Index fell 0.1% in August, bucking expectations of a rise and indicating a potential slowdown in overall economic growth. The decline was driven by a slump in the cost of services, particularly within wholesalers and retailers. The news has led to a drop in Treasury yields and solidifies expectations of an interest rate cut by the Federal Reserve next week.
The Hilton Kathmandu, once a symbol of Nepal's ambition and modern design, recently fell victim to violent anti-government protests. The hotel, built by the Shanker Group with a significant investment and featuring luxurious amenities and seismic safeguards, opened in 2024 but tragically, went up in flames a year later. The Hilton was not just a hotel, but a cultural statement, embodying Nepalese heritage and offering breathtaking views of the Langtang range.
In a shocking incident, a brand-new Mahindra Thar crashed through a glass wall and landed on the road below in Delhi's Preet Vihar. The SUV had just been purchased by a couple who were inside the vehicle at the time with a showroom salesman. Fortunately, no one was seriously injured in the accident. The incident, captured on video, has gone viral on social media. Police are investigating the cause of the incident.
Delhi-based manufacturer Vikas Ecotech has acquired an existing Plasticizer Manufacturing Business, valued at Rs 270 million, in an all-cash deal. With this acquisition, the company aims to enhance its product offering and become debt-free by 2023-24. This move comes after the firm recently paid off Rs 101 crore of its debt to lenders.
The Indian Express has obtained information that the Registrar General of India has requested a budget of Rs 14,618.95 crore for the upcoming Census 2027. This will be the first "digital census" and will include the collection of caste data through dedicated mobile applications. The option for self-enumeration will also be provided to the public. Additionally, Indian refiners have saved approximately $12.6 billion in the past three years through their Russian oil imports, which has caused tensions with the Trump administration.
The Trump administration's latest move has caused major disruptions in the Indian export industry with the imposition of 50% tariffs on Indian goods. Sectors such as apparel, textiles, gems, and jewelry will bear the brunt of the higher tariffs, putting low-skilled jobs in India at risk. India's response has been to extend tariff exemptions on cotton imports, but many are criticizing the government for not taking strong action against the US. Political figures like Saurabh Bhardwaj and Akhilesh Yadav have slammed the BJP-led government for its failed foreign and economic policies which are negatively impacting traders, manufacturers, and workers.